Business news – Page 45
-
NewsJim Ratcliffe, head of UK chemical giant Ineos, tops Sunday Times rich list
A net worth of more than £21 billion makes chemical engineer UK’s richest person
-
BusinessUS senators launch probe of Novartis’ payments to Trump lawyer
Congress demands info from Novartis about its $1.2m in outflows to Michael Cohen, just as it was negotiating payments for its cancer drug
-
BusinessTrump lays out plan to slash drug costs
White House strategy to reduce pharmaceutical prices faces backlash from the industry, which cautions against the ‘far-reaching’ proposals
-
BusinessTakeda set to swallow Shire
Shire’s US revenue and rare diseases portfolio grab Japanese firm’s attention
-
ArticleAre polymer medicines viable therapeutics?
Combining small-molecule medicines with polymers could offer big rewards for pharmaceutical researchers
-
ArticleThe dark side of chemical patents
Unloved, ignored and misunderstood but could all that change?
-
FeatureUnderstanding Alzheimer’s
After hundreds of failed drug candidates, James Mitchell Crow asks if this is the last roll of the dice for the amyloid theory of Alzheimer’s disease
-
BusinessBig business computing
Chemical and oil firms are using supercomputers to improve every part of their operations. Angeli Mehta reports
-
OpinionWhat the pay gap report really means
The UK pay gap data is an important first step, not the last word
-
Feature3D printing in pharma
Nina Notman explores how 3D printing is carving out a niche for itself in the pharmaceutical industry
-
NewsMardi Grass
The cannabis chemistry subdivision of the American Chemical Society takes to the streets of New Orleans
-
BusinessChemicals caught in the middle as tariffs loom
America’s chemicals and plastics industry stands to lose $5bn if US–China dispute escalates
-
BusinessDeal protects world’s biggest selling drug from biosimilar erosion
AbbVie and Samsung Bioepis resolve patent litigation over arthritis drug Humira
-
BusinessIndia creates national drugs database to address supply and quality issues
Regulatory body takes steps to reform how it manages and monitors pharmaceuticals
-
BusinessNovartis’ $8.7bn AveXis deal shows gene therapy appeal
Acquisition indicates the value of potentially permanent cures for inherited diseases
-
BusinessAkzoNobel sells off specialty chemicals arm in €10bn deal
Private equity firm Carlyle sees off several other bidders
-
-
OpinionWill robots make you redundant?
Smart machines could soon outpace even the best organic chemist
-
ResearchSolving the crystal maze
Workflow swaps gut feelings for data when designing continuous crystallisation processes
-
NewsWhat you need to know about neonicotinoids
The latest on the concerns raised about the pesticides’ impact on bees